Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/166546
Title: | IMMUNOMODULATORY ROLE OF HEPATITIS DELTA VIRUS (HDV) DURING HBV INFECTION | Authors: | THAM YAN LIN | Keywords: | Viral hepatitis, chronic liver disease, immunotherapy, CAR-T cell therapy | Issue Date: | 21-Aug-2019 | Citation: | THAM YAN LIN (2019-08-21). IMMUNOMODULATORY ROLE OF HEPATITIS DELTA VIRUS (HDV) DURING HBV INFECTION. ScholarBank@NUS Repository. | Abstract: | Hepatitis Delta virus (HDV) requires hepatitis B virus (HBV) to complete its infection cycle and causes a severe hepatitis with limited therapeutic options. To determine the prospect of T cell therapy in HBV/HDV co-infection, we first studied the HDV impact on viral antigen processing and presentation. Utilizing in vitro models of HBV/HDV co-infection, we demonstrated that HDV boosts HBV epitope presentation, both in HBV/HDV co-infected and neighboring mono-HBV infected cells through up-regulation of antigen processing pathway mediated by IFN-beta/lambda. This up-regulation was confirmed in liver biopsies of HBV/HDV patients. We then demonstrated in vitro and in HBV/HDV preclinical mouse model that HDV increases the antiviral efficacy of HBV-specific T cell receptors engineered T cells. Thus, by unveiling the effect of HDV on HBV antigen presentation, we provide a framework to better understand HBV/HDV immune pathology, and we advocate the use of engineered HBV-specific T cells for the treatment of HBV/HDV co-infection. | URI: | https://scholarbank.nus.edu.sg/handle/10635/166546 |
Appears in Collections: | Ph.D Theses (Open) |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
ThamYL.PDF | 4.6 MB | Adobe PDF | OPEN | None | View/Download |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.